| Literature DB >> 28218814 |
Paul Kennedy1,2, Lewis J Macgregor3, Eric Barnhill4, Curtis L Johnson5, Michael Perrins1, Angus Hunter3, Colin Brown6, Edwin J R van Beek1, Neil Roberts1.
Abstract
PURPOSE: To investigate the effect of warmup by application of the thermal agent Deep Heat (DH) on muscle mechanical properties using magnetic resonance elastography (MRE) at 3T before and after exercise-induced muscle damage (EIMD).Entities:
Keywords: MR elastography; exercise induced muscle damage; thigh
Mesh:
Year: 2017 PMID: 28218814 PMCID: PMC5600114 DOI: 10.1002/jmri.25642
Source DB: PubMed Journal: J Magn Reson Imaging ISSN: 1053-1807 Impact factor: 4.813
Figure 1Illustration of the biarticular structure of the RF muscle group. Knee reference angles described during the EIMD protocol are also annotated. Adapted with permission from muscleandmotion.net
Figure 2Wave images from a single image slice illustrating the wave propagation over eight phase offsets (a). A 3D volume rendering (b) of a T 2 acquisition shows the compression from the ring actuator which transmits externally generated waves into the tissue. The image plane is also labeled. In (c) the evolution of wave propagation across the eight phase offsets is depicted by plotting the displacement at a point (yellow marker in (a)) during each offset.
Figure 3(a) T 2‐weighted image and elastogram of the CIRS 049 test object and (b) plot of stiffness values measured for the four inclusions plotted against values given by the test object manufacturer.
Measured and Manufacturer Provided Values for Stiffness of Inclusions in CIRS 049 Test Object (Pa)
| Testing Method | Target 1 | Target 2 | Target 3 | Target 4 |
|---|---|---|---|---|
| Quasi‐static (manufactuer) | 2700 | 6000 | 16000 | 27000 |
| 3D Multi‐frequency MRE | 3731 ± 189 | 5722 ± 198 | 12827 ± 291 | 23713 ± 241 |
EIMD Protocol Performance Results and MVC Data for 20 Participants
| Subject | DH |
|
| MVC (Nm) | MVC change (%) | Workload (J) | Total Reps |
|---|---|---|---|---|---|---|---|
| 1 | No | No | No | 316 | −20 | 3871 | 156 |
| 2 | Yes | Yes | Yes | 269 | −55 | 3778 | 179 |
| 3 | No | No | No | 197 | −32 | 3227 | 224 |
| 4 | Yes | Yes | Yes | 355 | −51 | 5972 | 291 |
| 5 | No | Yes | No | 260 | −18 | 4538 | 349 |
| 6 | No | Yes | Yes | 213 | −55 | 4200 | 273 |
| 7 | Yes | No | Yes | 406 | −44 | 4789 | 152 |
| 8 | Yes | Yes | No | 220 | −34 | 5400 | 285 |
| 9 | No | Yes | No | 375 | −14 | 5193 | 365 |
| 10 | Yes | No | No | 213 | −4 | 3121 | 146 |
| 11 | No | No | No | 252 | 9 | 3722 | 147 |
| 12 | Yes | No | Yes | 254 | −18 | 5209 | 312 |
| 13 | No | Yes | Yes | 266 | −54 | 5055 | 326 |
| 14 | Yes | No | No | 227 | −31 | 6007 | 353 |
| 15 | No | No | No | 167 | −19 | 3245 | 124 |
| 16 | Yes | No | No | 276 | −12 | 5901 | 216 |
| 17 | No | No | No | 255 | −34 | 5773 | 296 |
| 18 | Yes | No | No | 219 | 1 | 3932 | 170 |
| 19 | No | No | No | 188 | −21 | 3619 | 177 |
| 20 | Yes | No | No | 222 | 3 | 3704 | 156 |
Participants highlighted with gray cells were excluded from the analysis (#10, #11, #13, #18, and #20). Participant #13 was removed due to the presence of an incidental finding.
Figure 4MVC force data for all participants at baseline and 2 days after EIMD protocol. The rectangles highlight the four participants in whom the reduction in MVC was <10%.
Figure 5Time course of (a) MVC, (b) CK concentration, and (c) pain at baseline and during recovery from the EIMD protocol. Error bars are omitted for clarity. SD values are presented in Table 3.
Mean Values of MVC, Pain Score, and CK Concentration Over the Study Period for the Seven Participants in the DH Group and the Eight Participants in the Control Group
| Measurement | MVC | Pain ( | CK ( | |||||
|---|---|---|---|---|---|---|---|---|
| Group | Control | DH | Control Ext | Control Flex | DH Ext | DH Flex | Control | DH |
| Baseline | 246.3 ± 66.5 | 286.9 ± 63.6 | 1.8 ± 1.2 | 1.5 ± 0.8 | 1.9 ± 1.1 | 1.6 ± 0.6 | 135 ± 58 | 199 ± 129 |
| 48 hours | 183.6 ± 69.7 | 181.9 ± 41.8 | 5.5 ± 5.5 | 4.3 ± 4.3 | 5.6 ± 3.3 | 3.4 ± 1.8 | 629 ± 381 | 833 ± 691 |
| 5 days | 216.2 ± 65.8 | 234.8 ± 32.2 | 3.4 ± 2.6 | 2.1 ± 0.8 | 2.2 ± 0.8 | 1.6 ± 0.7 | 716 ± 805 | 1491 ± 1457 |
| 7 days | 234.3 ± 71.2 | 247.7 ± 36.1 | 2.1 ± 1.4 | 1.6 ± 1.0 | 1.5 ± 1.0 | 1.3 ± 0.9 | 1513 ± 1246 | 1893 ± 1024 |
| 9 days | 240.0 ± 75.4 | 241.3 ± 28.4 | 2.0 ± 1.5 | 1.7 ± 1.6 | 1.4 ± 1.6 | 1.0 ± 0.6 | 737 ± 613 | 1196 ± 985 |
Figure 6T 2‐weighted images and maps of |G*| and φ for four participants. Hyperintensity on T 2‐weighted images suggests edema is present in the RF (a–d) and VI muscle groups (a,b). Less severe hyperintensity is denoted by red arrows.
Mean Values of the Magnitude of the Complex Shear Modulus (|G*| ± SD) and phase angle (φ) are Presented for the Rectus Femoris (RF), Vastus Intermedius (VI), Vastus Medialis (VM), Vastus Lateralis (VL), Quadriceps (Quad), and Hamstrings (Ham) in the DH and Control Groups at Baseline and After the EIMD protocol
| Control Group | Deep Heat Group | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| | | φ | | | φ | ||||||
| Muscle Group | Pre Damage | Post Damage | Pre Damage | Post Damage | Muscle Group | Pre Damage | Post Damage | Pre Damage | Post Damage |
| VM | 1.15 ± 0.18 | 1.12 ± 0.09 | 0.76 ± 0.07 | 0.86 ± 0.10* | VM | 1.19 ± 0.20 | 1.17 ± 0.22 | 0.84 ± 0.07 | 0.77 ± 0.09* |
| RF | 1.26 ± 0.37 | 1.48 ± 0.36* | 0.79 ± 0.08 | 0.85 ± 0.08 | RF | 1.23 ± 0.12 | 1.69 ± 0.37** | 0.80 ± 0.08 | 0.77 ± 0.10* |
| VI | 1.38 ± 0.20 | 1.35 ± 0.29 | 0.85 ± 0.08 | 0.89 ± 0.08 | VI | 1.24 ± 0.13 | 1.50 ± 0.29* | 0.82 ± 0.13 | 0.83 ± 0.08 |
| VL | 1.19 ± 0.16 | 1.23 ± 0.11 | 0.71 ± 0.06 | 0.79 ± 0.09 | VL | 1.21 ± 0.14 | 1.16 ± 0.04 | 0.74 ± 0.07 | 0.71 ± 0.05 |
| Quad | 1.15 ± 0.12 | 1.15 ± 0.10 | 0.80 ± 0.02 | 0.85 ± 0.05 | Quad | 1.17 ± 0.09 | 1.22 ± 0.10 | 0.82 ± 0.05 | 0.80 ± 0.04* |
| Ham | 1.04 ± 0.12 | 1.05 ± 0.09 | 0.82 ± 0.05 | 0.86 ± 0.06 | Ham | 1.03 ± 0.07 | 1.00 ± 0.05 | 0.82 ± 0.05 | 0.81 ± 0.03 |
Also presented are the significant results from Mann‐Whitney U‐tests assessing the significance of changes in |G*| and φ (*P < 0.03).
Figure 7Values of |G*| (upper row) and φ (lower row) in RF muscle for individual participants in the control (left column) and DH (right column) groups at baseline and 2 days after EIMD protocol.